FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014113885> ?p ?o ?g. }

• W2014113885 endingPage "981" @default.
• W2014113885 startingPage "971" @default.
• W2014113885 abstract "Purpose Commonly prescribed medications produce QT-prolongation and are associated with torsades de pointes in non-acutely ill patients. We examined patterns of QT-prolonging drug use in critically ill individuals. Methods An administrative critical care database was utilized to identify patients receiving drugs associated with QT-interval prolongation or torsades de pointes for ≥ 24 hours. Results Data from 212 016 individuals collected over a 63-month period was examined to identify 6125 patients (2.9%) receiving QT-interval prolonging drugs. These individuals had a mean (±SE) age of 63.0 (±0.2) years, were predominately male (55.4%) and Caucasian (84.4%), and were exposed to QT-interval prolonging agents for a mean (±SE) 53.1 (±0.4)% of their ICU length of stay. Respiratory and cardiovascular illnesses were the most common reasons for ICU admission (17.2, 12.0%, respectively). The most frequently administered agents were amiodarone (23.5%), haloperidol (19.8%), and levofloxacin (19.7%); no other single agent accounted for more than 10% of QT-interval prolonging drugs prescribed. Coadministration of QT-prolonging drugs occurred in 1139 patients (18.6%). These patients had higher ICU mortality rate and longer ICU lengths of stay, compared to patients not receiving coadministered drugs (p < 0.001 for both). For patients receiving coadministered drugs, overlap occurred for 71.4 (±0.8)% of the time that the drugs were given. Amiodarone coadministration with antibiotics, haloperidol coadministration with antibiotics, and haloperidol coadministration with amiodarone, comprised 15.2, 13.7, and 9.4%, of all coadministered agents, respectively. Conclusions QT-prolonging drugs were used in a minority of critically ill patients. Prospective evaluation in the ICU environment is necessary to determine whether administration of these agents is associated with adverse cardiac events comparable to those reported in ambulatory patients. Copyright © 2008 John Wiley & Sons, Ltd." @default.
• W2014113885 created "2016-06-24" @default.
• W2014113885 creator A5012355242 @default.
• W2014113885 creator A5012550644 @default.
• W2014113885 creator A5032078333 @default.
• W2014113885 creator A5033585717 @default.
• W2014113885 creator A5058411957 @default.
• W2014113885 date "2008-10-01" @default.
• W2014113885 modified "2023-10-16" @default.
• W2014113885 title "Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients" @default.
• W2014113885 cites W1966695702 @default.
• W2014113885 cites W1985642370 @default.
• W2014113885 cites W1997101969 @default.
• W2014113885 cites W2027879784 @default.
• W2014113885 cites W2033152505 @default.
• W2014113885 cites W2035713696 @default.
• W2014113885 cites W2046672383 @default.
• W2014113885 cites W2047620467 @default.
• W2014113885 cites W2053472798 @default.
• W2014113885 cites W2054184282 @default.
• W2014113885 cites W2061642122 @default.
• W2014113885 cites W2063294722 @default.
• W2014113885 cites W2066361244 @default.
• W2014113885 cites W2066538341 @default.
• W2014113885 cites W2082626069 @default.
• W2014113885 cites W2091503143 @default.
• W2014113885 cites W2093638125 @default.
• W2014113885 cites W2102816291 @default.
• W2014113885 cites W2118076848 @default.
• W2014113885 cites W2127125241 @default.
• W2014113885 cites W2131308754 @default.
• W2014113885 cites W2139732944 @default.
• W2014113885 cites W2145137957 @default.
• W2014113885 cites W2146506439 @default.
• W2014113885 cites W2151805453 @default.
• W2014113885 cites W2162857263 @default.
• W2014113885 cites W2163966221 @default.
• W2014113885 cites W2616625093 @default.
• W2014113885 cites W4293242440 @default.
• W2014113885 doi "https://doi.org/10.1002/pds.1637" @default.
• W2014113885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2587152" @default.
• W2014113885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18693297" @default.
• W2014113885 hasPublicationYear "2008" @default.
• W2014113885 type Work @default.
• W2014113885 sameAs 2014113885 @default.
• W2014113885 citedByCount "38" @default.
• W2014113885 countsByYear W20141138852012 @default.
• W2014113885 countsByYear W20141138852013 @default.
• W2014113885 countsByYear W20141138852014 @default.
• W2014113885 countsByYear W20141138852015 @default.
• W2014113885 countsByYear W20141138852016 @default.
• W2014113885 countsByYear W20141138852017 @default.
• W2014113885 countsByYear W20141138852019 @default.
• W2014113885 countsByYear W20141138852020 @default.
• W2014113885 countsByYear W20141138852021 @default.
• W2014113885 countsByYear W20141138852022 @default.
• W2014113885 countsByYear W20141138852023 @default.
• W2014113885 crossrefType "journal-article" @default.
• W2014113885 hasAuthorship W2014113885A5012355242 @default.
• W2014113885 hasAuthorship W2014113885A5012550644 @default.
• W2014113885 hasAuthorship W2014113885A5032078333 @default.
• W2014113885 hasAuthorship W2014113885A5033585717 @default.
• W2014113885 hasAuthorship W2014113885A5058411957 @default.
• W2014113885 hasBestOaLocation W20141138852 @default.
• W2014113885 hasConcept C118441451 @default.
• W2014113885 hasConcept C126322002 @default.
• W2014113885 hasConcept C177713679 @default.
• W2014113885 hasConcept C23276603 @default.
• W2014113885 hasConcept C2426938 @default.
• W2014113885 hasConcept C2778094803 @default.
• W2014113885 hasConcept C2779161974 @default.
• W2014113885 hasConcept C2780035454 @default.
• W2014113885 hasConcept C2780486423 @default.
• W2014113885 hasConcept C2780948584 @default.
• W2014113885 hasConcept C42219234 @default.
• W2014113885 hasConcept C513476851 @default.
• W2014113885 hasConcept C71924100 @default.
• W2014113885 hasConcept C97320921 @default.
• W2014113885 hasConcept C98274493 @default.
• W2014113885 hasConceptScore W2014113885C118441451 @default.
• W2014113885 hasConceptScore W2014113885C126322002 @default.
• W2014113885 hasConceptScore W2014113885C177713679 @default.
• W2014113885 hasConceptScore W2014113885C23276603 @default.
• W2014113885 hasConceptScore W2014113885C2426938 @default.
• W2014113885 hasConceptScore W2014113885C2778094803 @default.
• W2014113885 hasConceptScore W2014113885C2779161974 @default.
• W2014113885 hasConceptScore W2014113885C2780035454 @default.
• W2014113885 hasConceptScore W2014113885C2780486423 @default.
• W2014113885 hasConceptScore W2014113885C2780948584 @default.
• W2014113885 hasConceptScore W2014113885C42219234 @default.
• W2014113885 hasConceptScore W2014113885C513476851 @default.
• W2014113885 hasConceptScore W2014113885C71924100 @default.
• W2014113885 hasConceptScore W2014113885C97320921 @default.
• W2014113885 hasConceptScore W2014113885C98274493 @default.
• W2014113885 hasIssue "10" @default.
• W2014113885 hasLocation W20141138851 @default.
• W2014113885 hasLocation W20141138852 @default.
• W2014113885 hasLocation W20141138853 @default.

• next